Latest research

agbiopro

SARS-CoV-2 infected host cell proteomics reveal potential therapy targets

agbiopro

Vertex, CRISPR’s gene-editing treatment for blood disorders shows promise in early data

agbiopro

Metabolic landscape of the tumor microenvironment at single cell resolution

agbiopro

The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating S

agbiopro

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

agbiopro

Programmable bacteria induce durable tumor regression and systemic antitumor immunity

Synthetic biology is driving a new era of medicine through the genetic programming of living cells. One particular area of focus has been...

agbiopro

Reviving tired T cells to improve immuno-oncology treatments

agbiopro

Tumor Cell Dormancy—Triggered by the Niche

Dormant cancer cells often survive treatment and increase the risk for tumor relapse, associated with dismal prognosis. Two recent papers...

agbiopro

Gene-editing technology to create virus-resistant cassava plant has opposite effect

agbiopro

Big Data Takes on Cancer

agbiopro

Protein-slaying drugs could be the next blockbuster therapies